TY - JOUR
T1 - 2-{4-[3-(4-Aryl/heteroaryl-1-piperazinyl)propoxy]phenyl}-2H-benzotriaz-oles and their N-oxides as ligands for serotonin and dopamine receptors
AU - Sparatore, Anna
AU - Goegan, Mara
AU - Cagnotto, Alfredo
AU - Sparatore, Fabio
PY - 1999/6/30
Y1 - 1999/6/30
N2 - A small set of 2-{4-[3-(4-aryl/heteroaryl-piperazinyl)propoxy]phenyl}-2H-benzotriazoles and corresponding N-oxides were prepared. The synthesized compounds were able to bind on some serotonin (5-HT(1A), 5-HT(2A)) and dopamine (D2, D3) receptors, while displaying poor or no affinity for 5-HT(1B), 5-HT(2C), 5-HT3, and 5-HT4 subtypes. The strong contribution of the N-oxide function for the binding on 5-HT(1A), D2 and D3 receptors is noteworthy. For 2-{4-[3-[4-(2-methoxyphenyl)-1-piperazinyl]propoxy]phenyl}-2H-benzotriazol-1 -oxide (4b), the binding constants (K(i)) were 11.9 (5-HT(1A)) and 10.5 nM (D3). In a general pharmacological screening, the 2-(4-[3-(4-phenyl-1-piperazinyl)propoxy]phenyl}-2H-benzotriazole (3a) exhibited only very weak activities, with the exception of protecting mice from cyanide-induced hypoxia.
AB - A small set of 2-{4-[3-(4-aryl/heteroaryl-piperazinyl)propoxy]phenyl}-2H-benzotriazoles and corresponding N-oxides were prepared. The synthesized compounds were able to bind on some serotonin (5-HT(1A), 5-HT(2A)) and dopamine (D2, D3) receptors, while displaying poor or no affinity for 5-HT(1B), 5-HT(2C), 5-HT3, and 5-HT4 subtypes. The strong contribution of the N-oxide function for the binding on 5-HT(1A), D2 and D3 receptors is noteworthy. For 2-{4-[3-[4-(2-methoxyphenyl)-1-piperazinyl]propoxy]phenyl}-2H-benzotriazol-1 -oxide (4b), the binding constants (K(i)) were 11.9 (5-HT(1A)) and 10.5 nM (D3). In a general pharmacological screening, the 2-(4-[3-(4-phenyl-1-piperazinyl)propoxy]phenyl}-2H-benzotriazole (3a) exhibited only very weak activities, with the exception of protecting mice from cyanide-induced hypoxia.
KW - Benzotriazole-N-oxides
KW - Benzotriazoles
KW - Dopamine receptor ligands
KW - Serotonin receptor ligands
UR - http://www.scopus.com/inward/record.url?scp=0033617978&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033617978&partnerID=8YFLogxK
U2 - 10.1016/S0014-827X(99)00046-4
DO - 10.1016/S0014-827X(99)00046-4
M3 - Article
C2 - 10443019
AN - SCOPUS:0033617978
SN - 0014-827X
VL - 54
SP - 402
EP - 410
JO - Farmaco
JF - Farmaco
IS - 6
ER -